803 related articles for article (PubMed ID: 21074720)
1. Aberrant epigenetic landscape in cancer: how cellular identity goes awry.
Berdasco M; Esteller M
Dev Cell; 2010 Nov; 19(5):698-711. PubMed ID: 21074720
[TBL] [Abstract][Full Text] [Related]
2. DNA methylomes, histone codes and miRNAs: tying it all together.
Guil S; Esteller M
Int J Biochem Cell Biol; 2009 Jan; 41(1):87-95. PubMed ID: 18834952
[TBL] [Abstract][Full Text] [Related]
3. A new paradigm in toxicology and teratology: altering gene activity in the absence of DNA sequence variation.
Reamon-Buettner SM; Borlak J
Reprod Toxicol; 2007 Jul; 24(1):20-30. PubMed ID: 17596910
[TBL] [Abstract][Full Text] [Related]
4. Cancer epigenome.
Lechner M; Boshoff C; Beck S
Adv Genet; 2010; 70():247-76. PubMed ID: 20920751
[TBL] [Abstract][Full Text] [Related]
5. Interplay between different epigenetic modifications and mechanisms.
Murr R
Adv Genet; 2010; 70():101-41. PubMed ID: 20920747
[TBL] [Abstract][Full Text] [Related]
6. Approaches to target the genome and its epigenome in cancer.
Chapman-Rothe N; Brown R
Future Med Chem; 2009 Nov; 1(8):1481-95. PubMed ID: 21426061
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation and human disease.
Robertson KD
Nat Rev Genet; 2005 Aug; 6(8):597-610. PubMed ID: 16136652
[TBL] [Abstract][Full Text] [Related]
8. Epigenetics in prostate cancer: biologic and clinical relevance.
Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
[TBL] [Abstract][Full Text] [Related]
9. Cancer epigenetics.
Taby R; Issa JP
CA Cancer J Clin; 2010; 60(6):376-92. PubMed ID: 20959400
[TBL] [Abstract][Full Text] [Related]
10. Deciphering the cancer imprintome.
Monk D
Brief Funct Genomics; 2010 Jul; 9(4):329-39. PubMed ID: 20551091
[TBL] [Abstract][Full Text] [Related]
11. [Epigenetics-related diseases and analytic methods].
Soejima H
Rinsho Byori; 2009 Aug; 57(8):769-78. PubMed ID: 19764412
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker.
Tost J
Methods Mol Biol; 2009; 507():3-20. PubMed ID: 18987802
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of genomic imprinting and clinical implications for cancer.
Uribe-Lewis S; Woodfine K; Stojic L; Murrell A
Expert Rev Mol Med; 2011 Jan; 13():e2. PubMed ID: 21262060
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic changes in solid and hematopoietic tumors.
Toyota M; Issa JP
Semin Oncol; 2005 Oct; 32(5):521-30. PubMed ID: 16210093
[TBL] [Abstract][Full Text] [Related]
15. The necessity of a human epigenome project.
Esteller M
Carcinogenesis; 2006 Jun; 27(6):1121-5. PubMed ID: 16699174
[TBL] [Abstract][Full Text] [Related]
16. [Epigenome and human disease].
Ushijima T; Katsurano M; Asada K
Nihon Rinsho; 2009 Jun; 67(6):1219-26. PubMed ID: 19507518
[TBL] [Abstract][Full Text] [Related]
17. [Epigenetics of prostate cancer].
Yi XM; Zhou WQ
Zhonghua Nan Ke Xue; 2010 Jul; 16(7):635-41. PubMed ID: 20873600
[TBL] [Abstract][Full Text] [Related]
18. [DNA methylation: an epigenetic process of medical importance].
Rodríguez-Dorantes M; Téllez-Ascencio N; Cerbón MA; López M; Cervantes A
Rev Invest Clin; 2004; 56(1):56-71. PubMed ID: 15144044
[TBL] [Abstract][Full Text] [Related]
19. [Epigenome and cancer: new possibilities of cancer prevention and therapy?].
Paluszczak J; Baer-Dubowska W
Postepy Biochem; 2005; 51(3):244-50. PubMed ID: 16381168
[TBL] [Abstract][Full Text] [Related]
20. Diet, epigenetic, and cancer prevention.
Chen J; Xu X
Adv Genet; 2010; 71():237-55. PubMed ID: 20933131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
